The humoral immune response to the inactivated influenzaA (H1N1) 2009 monovalent vaccine in patients with Type2 diabetes mellitus in Korea

Diabetic Medicine

Volumn 28, Issue 7, 2011, Pages 815-817

  Nam, J S ^a   Kim, A R ^b   Yoon, J C ^b   Byun, Y ^c   Kim, S A ^a   Kim, K R ^a   Cho, S ^b   Seong, B L ^c   Ahn, C W ^d   Lee, J M ^b  

^a Department of Internal Medicine ^*  (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Severance Institute for Vascular and Metabolic Research   (South Korea)

Author keywords

Antibody seroconversion; InfluenzaA (H1N1) 2009 monovalent vaccine; Type2 diabetes mellitus

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADJUVANT THERAPY; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION; HUMAN; HUMORAL IMMUNITY; INFLUENZA VACCINATION; KOREA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEROCONVERSION; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ANTIBODY FORMATION; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; KOREA; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 79958775292     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03255.x     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 nomovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 1-8.
2. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-1944.
3. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J et al. Response after one dose of a monovalent influenzaA (H1N1) 2009 vaccine - preliminary report. N Engl J Med 2009; 361: 2405-2413.
4. Fauci AS. Statement by Dr Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, NIH, Regarding Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults. Available at Last accessed 12 November 2009.
5. Korean Food and Drug Administration. Report on the Effectiveness of Adjuvant Incorporated Vaccine against H1N1 Influenza (Greenflu-S plus, Green Cross). Available at) Last accessed 24 June 2010.
6. Lederman MM, Rodman HM, Schacter BZ, Jones PK, Schiffman G. Antibody response to pneumococcal polysaccharides in insulin-dependent diabetes mellitus. Diabetes Care 1982; 5: 36-39.
7. WHO. Manual on Animal Influenza Diagnosis and Surveillance (WHO/CDS/CSR/NCS/2002.5). Geneva: World Health Organization, 2002. Available at CSR/ Publications/manual on animal ai diagnosis and surveillance.pdf
8. Zhu Q, Chang H, Chen Y, Fang F, Xue C, Zhang F et al. Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice. Biochem Biophys Res Commun 2005; 329: 87-94.
9. Pozzilli P, Gale EAM, Visalli N, Baroni M, Crovari P, Frighi V et al. The immune response to influenza vaccination in diabetic patients. Diabetologia 1986; 29: 850-854.
10. Brydak LB, Machala M. Humoral immune response to influenza vaccination in patients from high-risk groups. Drugs 2000; 60: 35-53.
11. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev 2001; 2: 131-140.
12. Jain S, Kamimoto L, Bramley AM, Schimitz AM, Benoit SR, Louie J et al. Hospitalized patients with 2009 H1N1 influnza in the United States, April-Jun 3 2009. N Engl J Med 2009; 361: 1935-1944.